{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:10:54Z","timestamp":1793373054757,"version":"4.5.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471415"],"award-info":[{"award-number":["81471415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31600951"],"award-info":[{"award-number":["31600951"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500063"],"award-info":[{"award-number":["81500063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873740"],"award-info":[{"award-number":["81873740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Basic Research Plan in Shaanxi Province of China","award":["2017JM8086"],"award-info":[{"award-number":["2017JM8086"]}]},{"name":"Natural Science Basic Research Plan in Shaanxi Province of China","award":["2017JQ8048"],"award-info":[{"award-number":["2017JQ8048"]}]},{"name":"The Leading Disciplines Development Government Foundation of Shaanxi"},{"name":"Xi\u2019an Medical University\u2019s key disciplines of molecular immunology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12017-018-8518-6","type":"journal-article","created":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T21:58:36Z","timestamp":1546379916000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["The Emerging Roles of Ferroptosis in Huntington\u2019s Disease"],"prefix":"10.1007","volume":"21","author":[{"given":"Yajing","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchun","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"key":"8518_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fnins.2018.00466","volume":"12","author":"M Abdalkader","year":"2018","unstructured":"Abdalkader, M., Lampinen, R., Kanninen, K. M., Malm, T. M., & Liddell, J. R. (2018). Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Frontiers in Neuroscience, 12, 466. https:\/\/doi.org\/10.3389\/fnins.2018.00466 .","journal-title":"Frontiers in Neuroscience"},{"issue":"5","key":"8518_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","volume":"38","author":"JPF Angeli","year":"2017","unstructured":"Angeli, J. P. F., Shah, R., Pratt, D. A., & Conrad, M. (2017). Ferroptosis inhibition: Mechanisms and opportunities. Trends in Pharmacological Sciences, 38(5), 489\u2013498. https:\/\/doi.org\/10.1016\/j.tips.2017.02.005 .","journal-title":"Trends in Pharmacological Sciences"},{"key":"8518_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2013.04.017","volume":"62","author":"S Ayala-Pena","year":"2013","unstructured":"Ayala-Pena, S. (2013). Role of oxidative DNA damage in mitochondrial dysfunction and Huntington\u2019s disease pathogenesis. Free Radical Biology and Medicine, 62, 102\u2013110. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.04.017 .","journal-title":"Free Radical Biology and Medicine"},{"issue":"4","key":"8518_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","volume":"85","author":"L Baird","year":"2011","unstructured":"Baird, L., & Dinkova-Kostova, A. T. (2011). The cytoprotective role of the Keap1-Nrf2 pathway. Archives of Toxicology, 85(4), 241\u2013272. https:\/\/doi.org\/10.1007\/s00204-011-0674-5 .","journal-title":"Archives of Toxicology"},{"issue":"5","key":"8518_CR5","first-page":"741","volume":"43","author":"B Barbiroli","year":"1997","unstructured":"Barbiroli, B., Frassineti, C., Martinelli, P., Iotti, S., Lodi, R., Cortelli, P., & Montagna, P. (1997). Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cellular and Molecular Biology (Noisy-le-grand), 43(5), 741\u2013749.","journal-title":"Cellular and Molecular Biology (Noisy-le-grand)"},{"issue":"10","key":"8518_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","volume":"32","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis, G., Lu, P. H., Tishler, T. A., Fong, S. M., Oluwadara, B., Finn, J. P.,\u2026 Perlman, S. (2007). Myelin breakdown and iron changes in Huntington\u2019s disease: Pathogenesis and treatment implications. Neurochemical Research, 32(10), 1655\u20131664. https:\/\/doi.org\/10.1007\/s11064-007-9352-7 .","journal-title":"Neurochemical Research"},{"issue":"14","key":"8518_CR7","doi-asserted-by":"publisher","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","volume":"285","author":"J Bradford","year":"2010","unstructured":"Bradford, J., Shin, J. Y., Roberts, M., Wang, C. E., Sheng, G., Li, S., & Li, X. J. (2010). Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. Journal of Biological Chemistry, 285(14), 10653\u201310661. https:\/\/doi.org\/10.1074\/jbc.M109.083287 .","journal-title":"Journal of Biological Chemistry"},{"issue":"11\u201312","key":"8518_CR8","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","volume":"8","author":"SE Browne","year":"2006","unstructured":"Browne, S. E., & Beal, M. F. (2006). Oxidative damage in Huntington\u2019s disease pathogenesis. Antioxidants & Redox Signaling, 8(11\u201312), 2061\u20132073. https:\/\/doi.org\/10.1089\/ars.2006.8.2061 .","journal-title":"Antioxidants & Redox Signaling"},{"issue":"11\u201312","key":"8518_CR9","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao, J. Y., & Dixon, S. J. (2016). Mechanisms of ferroptosis. Cellular and Molecular Life Sciences, 73(11\u201312), 2195\u20132209. https:\/\/doi.org\/10.1007\/s00018-016-2194-1 .","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"3","key":"8518_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/mp.2016.196","volume":"22","author":"BR Cardoso","year":"2017","unstructured":"Cardoso, B. R., Hare, D. J., Bush, A. I., & Roberts, B. R. (2017). Glutathione peroxidase 4: A new player in neurodegeneration? Molecular Psychiatry, 22(3), 328\u2013335. https:\/\/doi.org\/10.1038\/mp.2016.196 .","journal-title":"Molecular Psychiatry"},{"issue":"4","key":"8518_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuron.2006.07.011","volume":"51","author":"JH Cheah","year":"2006","unstructured":"Cheah, J. H., Kim, S. F., Hester, L. D., Clancy, K. W., Patterson, S. E. 3rd, Papadopoulos, V., & Snyder, S. H. (2006). NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron, 51(4), 431\u2013440. https:\/\/doi.org\/10.1016\/j.neuron.2006.07.011 .","journal-title":"Neuron"},{"issue":"10","key":"8518_CR12","doi-asserted-by":"publisher","first-page":"e77023","DOI":"10.1371\/journal.pone.0077023","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen, J., Marks, E., Lai, B., Zhang, Z., Duce, J. A., Lam, L. Q., Volitakis, I., Bush, A. I., Hersch, S., & Fox, J. H. (2013). Iron accumulates in Huntington\u2019s disease neurons: Protection by deferoxamine. PLoS ONE, 8(10), e77023. https:\/\/doi.org\/10.1371\/journal.pone.0077023 .","journal-title":"PLoS ONE"},{"issue":"47","key":"8518_CR13","doi-asserted-by":"publisher","first-page":"28097","DOI":"10.1074\/jbc.M115.680090","volume":"290","author":"L Chen","year":"2015","unstructured":"Chen, L., Hambright, W. S., Na, R., & Ran, Q. (2015). Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. Journal of Biological Chemistry, 290(47), 28097\u201328106. https:\/\/doi.org\/10.1074\/jbc.M115.680090 .","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"8518_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.4103\/1673-5374.228762","volume":"13","author":"SY Cheng","year":"2018","unstructured":"Cheng, S. Y., Wang, S. C., Lei, M., Wang, Z., & Xiong, K. (2018). Regulatory role of calpain in neuronal death. Neural Regeneration Research, 13(3), 556\u2013562. https:\/\/doi.org\/10.4103\/1673-5374.228762 .","journal-title":"Neural Regeneration Research"},{"key":"8518_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuroscience.2013.08.043","volume":"253","author":"BR Choi","year":"2013","unstructured":"Choi, B. R., Bang, S., Chen, Y., Cheah, J. H., & Kim, S. F. (2013). PKA modulates iron trafficking in the striatum via small GTPase. Rhes. Neuroscience, 253, 214\u2013220. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.08.043 .","journal-title":"Rhes. Neuroscience"},{"issue":"14","key":"8518_CR16","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo, Y. S., Johnson, G. V., MacDonald, M., Detloff, P. J., & Lesort, M. (2004). Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Human Molecular Genetics, 13(14), 1407\u20131420.","journal-title":"Human Molecular Genetics"},{"issue":"9\u201310","key":"8518_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1101\/gad.314674.118","volume":"32","author":"M Conrad","year":"2018","unstructured":"Conrad, M., Kagan, V. E., Bayir, H., Pagnussat, G. C., Head, B., Traber, M. G., & Stockwell, B. R. (2018). Regulation of lipid peroxidation and ferroptosis in diverse species. Genes & Development, 32(9\u201310), 602\u2013619. https:\/\/doi.org\/10.1101\/gad.314674.118 .","journal-title":"Genes & Development"},{"issue":"4","key":"8518_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti, A., Benner, C., Kerman, B. E., Gosselin, D., Lagier-Tourenne, C., Zuccato, C., Cattaneo, E., Gage, F. H., Cleveland, D. W., & Glass, C. K. (2014). Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nature Neuroscience, 17(4), 513\u2013521. https:\/\/doi.org\/10.1038\/nn.3668 .","journal-title":"Nature Neuroscience"},{"issue":"1","key":"8518_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006). Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127(1), 59\u201369. https:\/\/doi.org\/10.1016\/j.cell.2006.09.015 .","journal-title":"Cell"},{"issue":"7","key":"8518_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/ars.2015.6343","volume":"24","author":"E Deas","year":"2016","unstructured":"Deas, E., Cremades, N., Angelova, P. R., Ludtmann, M. H., Yao, Z., Chen, S.,\u2026 Abramov, A. Y. (2016). Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s Disease. Antioxidants & Redox Signaling, 24(7), 376\u2013391. https:\/\/doi.org\/10.1089\/ars.2015.6343 .","journal-title":"Antioxidants & Redox Signaling"},{"key":"8518_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14379","author":"AT Dinkova-Kostova","year":"2018","unstructured":"Dinkova-Kostova, A. T., Kostov, R. V., & Kazantsev, A. G. (2018). The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS Journal. https:\/\/doi.org\/10.1111\/febs.14379 .","journal-title":"FEBS Journal"},{"issue":"1","key":"8518_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/imr.12533","volume":"277","author":"SJ Dixon","year":"2017","unstructured":"Dixon, S. J. (2017). Ferroptosis: Bug or feature? Immunological Reviews, 277(1), 150\u2013157. https:\/\/doi.org\/10.1111\/imr.12533 .","journal-title":"Immunological Reviews"},{"issue":"5","key":"8518_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E.,\u2026, Stockwell, B. R. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042 .","journal-title":"Cell"},{"issue":"11","key":"8518_CR24","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.chembiol.2014.09.019","volume":"21","author":"DA East","year":"2014","unstructured":"East, D. A., Fagiani, F., Crosby, J., Georgakopoulos, N. D., Bertrand, H., Schaap, M.,\u2026 Campanella, M. (2014). PMI: A DeltaPsim independent pharmacological regulator of mitophagy. Chemistry & Biology, 21(11), 1585\u20131596. https:\/\/doi.org\/10.1016\/j.chembiol.2014.09.019 .","journal-title":"Chemistry & Biology"},{"issue":"12","key":"8518_CR25","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J.,\u2026 Conrad, M. (2014). Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nature Cell Biology, 16(12), 1180\u20131191. https:\/\/doi.org\/10.1038\/ncb3064 .","journal-title":"Nature Cell Biology"},{"issue":"1","key":"8518_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-017-0628-x","volume":"19","author":"M Gerwyn","year":"2017","unstructured":"Gerwyn, M., & Maes, M. (2017). Mechanisms explaining muscle fatigue and muscle pain in patients with myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): A review of recent findings. Current Rheumatology Reports, 19(1), 1. https:\/\/doi.org\/10.1007\/s11926-017-0628-x .","journal-title":"Current Rheumatology Reports"},{"issue":"8","key":"8518_CR27","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0022-2275(20)32182-9","volume":"39","author":"AW Girotti","year":"1998","unstructured":"Girotti, A. W. (1998). Lipid hydroperoxide generation, turnover, and effector action in biological systems. Journal of Lipid Research, 39(8), 1529\u20131542.","journal-title":"Journal of Lipid Research"},{"key":"8518_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12883-015-0331-3","volume":"15","author":"G Grolez","year":"2015","unstructured":"Grolez, G., Moreau, C., Sablonniere, B., Garcon, G., Devedjian, J. C., Meguig, S.,\u2026 Devos, D. (2015). Ceruloplasmin activity and iron chelation treatment of patients with Parkinson\u2019s disease. BMC Neurology, 15, 74. https:\/\/doi.org\/10.1186\/s12883-015-0331-3 .","journal-title":"BMC Neurology"},{"issue":"Pt 4","key":"8518_CR29","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/brain\/awr333","volume":"135","author":"R Grondin","year":"2012","unstructured":"Grondin, R., Kaytor, M. D., Ai, Y., Nelson, P. T., Thakker, D. R., Heisel, J.,\u2026 Kaemmerer, W. F. (2012). Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum. Brain, 135(Pt 4), 1197\u20131209. https:\/\/doi.org\/10.1093\/brain\/awr333 .","journal-title":"Brain"},{"issue":"12","key":"8518_CR30","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1172\/JCI70911","volume":"123","author":"X Guo","year":"2013","unstructured":"Guo, X., Disatnik, M. H., Monbureau, M., Shamloo, M., Mochly-Rosen, D., & Qi, X. (2013). Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration. The Journal of Clinical Investigation, 123(12), 5371\u20135388. https:\/\/doi.org\/10.1172\/JCI70911 .","journal-title":"The Journal of Clinical Investigation"},{"issue":"7","key":"8518_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.38.7.450","volume":"38","author":"LW Ho","year":"2001","unstructured":"Ho, L. W., Brown, R., Maxwell, M., Wyttenbach, A., & Rubinsztein, D. C. (2001). Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington\u2019s disease. Journal of Medical Genetics, 38(7), 450\u2013452.","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"8518_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold, I., Berndt, C., Schmitt, S., Doll, S., Poschmann, G., Buday, K.,\u2026 Conrad, M. (2018). Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell, 172(3), 409\u2013422 e421. https:\/\/doi.org\/10.1016\/j.cell.2017.11.048 .","journal-title":"Cell"},{"issue":"10","key":"8518_CR33","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","volume":"10","author":"NR Jana","year":"2001","unstructured":"Jana, N. R., Zemskov, E. A., Wang, G., & Nukina, N. (2001). Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Human Molecular Genetics, 10(10), 1049\u20131059.","journal-title":"Human Molecular Genetics"},{"key":"8518_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024240","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez, M., Licitra, F., Underwood, B. R., & Rubinsztein, D. C. (2017) Huntington\u2019s disease: Mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harbor Perspectives in Medicine. https:\/\/doi.org\/10.1101\/cshperspect.a024240 .","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"10","key":"8518_CR35","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/nu4101399","volume":"4","author":"WM Johnson","year":"2012","unstructured":"Johnson, W. M., Wilson-Delfosse, A. L., & Mieyal, J. J. (2012). Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients, 4(10), 1399\u20131440. https:\/\/doi.org\/10.3390\/nu4101399 .","journal-title":"Nutrients"},{"issue":"3","key":"8518_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tips.2015.01.005","volume":"36","author":"YB Joshi","year":"2015","unstructured":"Joshi, Y. B., Giannopoulos, P. F., & Pratico, D. (2015). The 12\/15-lipoxygenase as an emerging therapeutic target for Alzheimer\u2019s disease. Trends in Pharmacological Sciences, 36(3), 181\u2013186. https:\/\/doi.org\/10.1016\/j.tips.2015.01.005 .","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"8518_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/biof.5520300301","volume":"30","author":"DW Kim","year":"2007","unstructured":"Kim, D. W., Hwang, I. K., Yoo, K. Y., Won, C. K., Moon, W. K., & Won, M. H. (2007). Coenzyme Q_{10} effects on manganese superoxide dismutase and glutathione peroxidase in the hairless mouse skin induced by ultraviolet B irradiation. Biofactors, 30(3), 139\u2013147.","journal-title":"Biofactors"},{"issue":"12","key":"8518_CR38","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1007\/s00415-007-0611-y","volume":"254","author":"N Klepac","year":"2007","unstructured":"Klepac, N., Relja, M., Klepac, R., Hecimovic, S., Babic, T., & Trkulja, V. (2007). Oxidative stress parameters in plasma of Huntington\u2019s disease patients, asymptomatic Huntington\u2019s disease gene carriers and healthy subjects: A cross-sectional study. Journal of Neurology, 254(12), 1676\u20131683. https:\/\/doi.org\/10.1007\/s00415-007-0611-y .","journal-title":"Journal of Neurology"},{"issue":"3","key":"8518_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/FBP.0b013e32833a5bf4","volume":"21","author":"P Kumar","year":"2010","unstructured":"Kumar, P., Kalonia, H., & Kumar, A. (2010). Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington\u2019s disease. Behavioural Pharmacology, 21(3), 217\u2013230.","journal-title":"Behavioural Pharmacology"},{"issue":"6","key":"8518_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/03630269.2014.965781","volume":"38","author":"KH Kuo","year":"2014","unstructured":"Kuo, K. H., & Mrkobrada, M. (2014). A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with beta-thalassemia. Hemoglobin, 38(6), 409\u2013421. https:\/\/doi.org\/10.3109\/03630269.2014.965781 .","journal-title":"Hemoglobin"},{"issue":"12","key":"8518_CR41","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1172\/JCI64484","volume":"122","author":"W Kwan","year":"2012","unstructured":"Kwan, W., Trager, U., Davalos, D., Chou, A., Bouchard, J., Andre, R.,\u2026 Muchowski, P. J. (2012). Mutant huntingtin impairs immune cell migration in Huntington disease. The Journal of Clinical Investigation, 122(12), 4737\u20134747. https:\/\/doi.org\/10.1172\/JCI64484 .","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"8518_CR42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","volume":"96","author":"BR Leavitt","year":"2006","unstructured":"Leavitt, B. R., van Raamsdonk, J. M., Shehadeh, J., Fernandes, H., Murphy, Z.,\u2026 Hayden, M. R. (2006). Wild-type huntingtin protects neurons from excitotoxicity. Journal of Neurochemistry, 96(4), 1121\u20131129. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03605.x .","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"8518_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-010-0788-5","volume":"121","author":"J Lee","year":"2011","unstructured":"Lee, J., Kosaras, B., Del Signore, S. J., Cormier, K., McKee, A., Ratan, R. R., Kowall, N. W., & Ryu, H. (2011). Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington\u2019s disease mice. Acta Neuropathologica, 121(4), 487\u2013498. https:\/\/doi.org\/10.1007\/s00401-010-0788-5 .","journal-title":"Acta Neuropathologica"},{"issue":"6","key":"8518_CR44","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E., Ambrose, C. M., Duyao, M. P., Myers, R. H., Lin, C., Srinidhi, L.,... MacFarlane, H. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell, 72(6), 971\u2013983.","journal-title":"Cell"},{"key":"8518_CR45","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7115","author":"M Maiorino","year":"2017","unstructured":"Maiorino, M., Conrad, M., & Ursini, F. (2017). GPx4, lipid peroxidation, and cell death: Discoveries, rediscoveries, and open issues. Antioxidants & Redox Signaling. https:\/\/doi.org\/10.1089\/ars.2017.7115 .","journal-title":"Antioxidants & Redox Signaling"},{"issue":"8","key":"8518_CR46","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10571-007-9220-7","volume":"27","author":"P Majumder","year":"2007","unstructured":"Majumder, P., Raychaudhuri, S., Chattopadhyay, B., & Bhattacharyya, N. P. (2007). Increased caspase-2, calpain activations and decreased mitochondrial complex II activity in cells expressing exogenous huntingtin exon 1 containing CAG repeat in the pathogenic range. Cellular and Molecular Neurobiology, 27(8), 1127\u20131145. https:\/\/doi.org\/10.1007\/s10571-007-9220-7 .","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"7","key":"8518_CR47","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/j.1460-9568.2006.04686.x","volume":"23","author":"Z Mao","year":"2006","unstructured":"Mao, Z., Choo, Y. S., & Lesort, M. (2006). Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington\u2019s disease knock-in striatal cells. European Journal of Neuroscience, 23(7), 1701\u20131710. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04686.x .","journal-title":"European Journal of Neuroscience"},{"issue":"15","key":"8518_CR48","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","volume":"95","author":"RT Matthews","year":"1998","unstructured":"Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998). Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proceedings of the National Academy of Sciences, 95(15), 8892\u20138897.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"12","key":"8518_CR49","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/mt.2011.219","volume":"19","author":"JL McBride","year":"2011","unstructured":"McBride, J. L., Pitzer, M. R., Boudreau, R. L., Dufour, B., Hobbs, T., Ojeda, S. R., & Davidson, B. L. (2011). Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease. Molecular Therapy, 19(12), 2152\u20132162. https:\/\/doi.org\/10.1038\/mt.2011.219 .","journal-title":"Molecular Therapy"},{"issue":"6","key":"8518_CR50","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1074\/jbc.M113.536912","volume":"289","author":"RG Mealer","year":"2014","unstructured":"Mealer, R. G., Murray, A. J., Shahani, N., Subramaniam, S., & Snyder, S. H. (2014). Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy. Journal of Biological Chemistry, 289(6), 3547\u20133554. https:\/\/doi.org\/10.1074\/jbc.M113.536912 .","journal-title":"Journal of Biological Chemistry"},{"issue":"18","key":"8518_CR51","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1113\/JP271957","volume":"594","author":"TL Merry","year":"2016","unstructured":"Merry, T. L., & Ristow, M. (2016). Nuclear factor erythroid-derived 2-like 2 (NFE2L2, Nrf2) mediates exercise-induced mitochondrial biogenesis and the anti-oxidant response in mice. The Journal of Physiology, 594(18), 5195\u20135207. https:\/\/doi.org\/10.1113\/JP271957 .","journal-title":"The Journal of Physiology"},{"issue":"3","key":"8518_CR52","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s12035-013-8477-8","volume":"48","author":"G Morris","year":"2013","unstructured":"Morris, G., Anderson, G., Berk, M., & Maes, M. (2013). Coenzyme Q10 depletion in medical and neuropsychiatric disorders: Potential repercussions and therapeutic implications. Molecular Neurobiology, 48(3), 883\u2013903. https:\/\/doi.org\/10.1007\/s12035-013-8477-8 .","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"8518_CR53","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","volume":"53","author":"G Morris","year":"2016","unstructured":"Morris, G., Berk, M., Galecki, P., Walder, K., & Maes, M. (2016). The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Molecular Neurobiology, 53(2), 1195\u20131219. https:\/\/doi.org\/10.1007\/s12035-015-9090-9 .","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"8518_CR54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jnc.12739","volume":"130","author":"M Muller","year":"2014","unstructured":"Muller, M., & Leavitt, B. R. (2014). Iron dysregulation in Huntington\u2019s disease. Journal of Neurochemistry, 130(3), 328\u2013350. https:\/\/doi.org\/10.1111\/jnc.12739 .","journal-title":"Journal of Neurochemistry"},{"issue":"11","key":"8518_CR55","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr, A. L., Li, S., Wang, C. E., Li, H., Wang, J., Rong, J.,\u2026 Li, X. J. (2008). N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. Journal of Neuroscience, 28(11), 2783\u20132792. https:\/\/doi.org\/10.1523\/JNEUROSCI.0106-08.2008 .","journal-title":"Journal of Neuroscience"},{"issue":"7498","key":"8518_CR56","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature13136","volume":"509","author":"BD Paul","year":"2014","unstructured":"Paul, B. D., Sbodio, J. I., Xu, R., Vandiver, M. S., Cha, J. Y., Snowman, A. M., & Snyder, S. H. (2014). Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington\u2019s disease. Nature, 509(7498), 96\u2013100. https:\/\/doi.org\/10.1038\/nature13136 .","journal-title":"Nature"},{"issue":"1","key":"8518_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1874609809666151124231127","volume":"9","author":"KN Prasad","year":"2016","unstructured":"Prasad, K. N., & Bondy, S. C. (2016). Inhibition of early biochemical defects in prodromal Huntington\u2019s Disease by simultaneous activation of Nrf2 and elevation of multiple micronutrients. Current Aging Science, 9(1), 61\u201370.","journal-title":"Current Aging Science"},{"issue":"9","key":"8518_CR58","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim, T., Wiltshire, K., Day, L., Dykeman, J., Steeves, T., & Jette, N. (2012). The incidence and prevalence of Huntington\u2019s disease: A systematic review and meta-analysis. Movement Disorders, 27(9), 1083\u20131091. https:\/\/doi.org\/10.1002\/mds.25075 .","journal-title":"Movement Disorders"},{"key":"8518_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-018-0173-9","author":"B Proneth","year":"2018","unstructured":"Proneth, B., & Conrad, M. (2018). Ferroptosis and necroinflammation, a yet poorly explored link. Cell Death & Differentiation. https:\/\/doi.org\/10.1038\/s41418-018-0173-9 .","journal-title":"Cell Death & Differentiation"},{"issue":"7","key":"8518_CR60","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.chembiol.2016.05.015","volume":"23","author":"L Quinti","year":"2016","unstructured":"Quinti, L., Casale, M., Moniot, S., Pais, T. F., Van Kanegan, M. J.,\u2026 Kazantsev, A. G. (2016). SIRT2- and NRF2-targeting thiazole-containing compound with therapeutic activity in Huntington\u2019s Disease models. Cell Chemical Biology, 23(7), 849\u2013861. https:\/\/doi.org\/10.1016\/j.chembiol.2016.05.015 .","journal-title":"Cell Chemical Biology"},{"issue":"23","key":"8518_CR61","doi-asserted-by":"publisher","first-page":"E4676","DOI":"10.1073\/pnas.1614943114","volume":"114","author":"L Quinti","year":"2017","unstructured":"Quinti, L., Dayalan Naidu, S., Trager, U., Chen, X., Kegel-Gleason, K., Lleres, D.,\u2026 Kazantsev, A. G. (2017). KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington\u2019s disease patients. Proceedings of the National Academy of Sciences, 114(23), E4676\u2013E4685. https:\/\/doi.org\/10.1073\/pnas.1614943114 .","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"53","key":"8518_CR62","doi-asserted-by":"publisher","first-page":"55137","DOI":"10.1074\/jbc.M410387200","volume":"279","author":"Q Ran","year":"2004","unstructured":"Ran, Q., Liang, H., Gu, M., Qi, W., Walter, C. A., Roberts, L. J. 2nd,\u2026 Van Remmen, H. (2004). Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. Journal of Biological Chemistry, 279(53), 55137\u201355146. https:\/\/doi.org\/10.1074\/jbc.M410387200 .","journal-title":"Journal of Biological Chemistry"},{"issue":"1\u20132","key":"8518_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","volume":"67","author":"PH Reddy","year":"2011","unstructured":"Reddy, P. H., Reddy, T. P., Manczak, M., Calkins, M. J., Shirendeb, U., & Mao, P. (2011). Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Research Reviews, 67(1\u20132), 103\u2013118. https:\/\/doi.org\/10.1016\/j.brainresrev.2010.11.004 .","journal-title":"Brain Research Reviews"},{"issue":"2","key":"8518_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbadis.2011.10.016","volume":"1822","author":"PH Reddy","year":"2012","unstructured":"Reddy, P. H., & Shirendeb, U. P. (2012). Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington\u2019s disease. Biochimica et Biophysica Acta, 1822(2), 101\u2013110. https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.016 .","journal-title":"Biochimica et Biophysica Acta"},{"issue":"7","key":"8518_CR65","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","volume":"69","author":"HD Rosas","year":"2012","unstructured":"Rosas, H. D., Chen, Y. I., Doros, G., Salat, D. H., Chen, N. K., Kwong, K. K.,\u2026 Hersch, S. M. (2012). Alterations in brain transition metals in Huntington disease: An evolving and intricate story. Archives of Neurology, 69(7), 887\u2013893. https:\/\/doi.org\/10.1001\/archneurol.2011.2945 .","journal-title":"Archives of Neurology"},{"issue":"7","key":"8518_CR66","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","volume":"66","author":"A Rosenblatt","year":"2006","unstructured":"Rosenblatt, A., Liang, K. Y., Zhou, H., Abbott, M. H., Gourley, L. M., Margolis, R. L., Brandt, J., & Ross, C. A. (2006). The association of CAG repeat length with clinical progression in Huntington disease. Neurology, 66(7), 1016\u20131020. https:\/\/doi.org\/10.1212\/01.wnl.0000204230.16619.d9 .","journal-title":"Neurology"},{"issue":"1","key":"8518_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross, C. A., & Tabrizi, S. J. (2011). Huntington\u2019s disease: From molecular pathogenesis to clinical treatment. The Lancet Neurology, 10(1), 83\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(10)70245-3 .","journal-title":"The Lancet Neurology"},{"issue":"4","key":"8518_CR68","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/WCO.0b013e328304b692","volume":"21","author":"E Roze","year":"2008","unstructured":"Roze, E., Saudou, F., & Caboche, J. (2008). Pathophysiology of Huntington\u2019s disease: From huntingtin functions to potential treatments. Current Opinion in Neurology, 21(4), 497\u2013503. https:\/\/doi.org\/10.1097\/WCO.0b013e328304b692 .","journal-title":"Current Opinion in Neurology"},{"issue":"3","key":"8518_CR69","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000334273","volume":"9","author":"R Sandhir","year":"2012","unstructured":"Sandhir, R., Sood, A., Mehrotra, A., & Kamboj, S. S. (2012). N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease. Neurodegenerative Diseases, 9(3), 145\u2013157. https:\/\/doi.org\/10.1159\/000334273 .","journal-title":"Neurodegenerative Diseases"},{"issue":"3","key":"8518_CR70","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","volume":"8","author":"A Seiler","year":"2008","unstructured":"Seiler, A., Schneider, M., Forster, H., Roth, S., Wirth, E. K., Culmsee, C.,\u2026 Conrad, M. (2008). Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metabolism, 8(3), 237\u2013248. https:\/\/doi.org\/10.1016\/j.cmet.2008.07.005 .","journal-title":"Cell Metabolism"},{"issue":"2","key":"8518_CR71","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/hmg\/ddr475","volume":"21","author":"UP Shirendeb","year":"2012","unstructured":"Shirendeb, U. P., Calkins, M. J., Manczak, M., Anekonda, V., Dufour, B., McBride, J. L., Mao, P., & Reddy, P. H. (2012). Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease. Human Molecular Genetics, 21(2), 406\u2013420. https:\/\/doi.org\/10.1093\/hmg\/ddr475 .","journal-title":"Human Molecular Genetics"},{"issue":"10","key":"8518_CR72","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/glia.20526","volume":"55","author":"DA Simmons","year":"2007","unstructured":"Simmons, D. A., Casale, M., Alcon, B., Pham, N., Narayan, N., & Lynch, G. (2007). Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease. Glia, 55(10), 1074\u20131084. https:\/\/doi.org\/10.1002\/glia.20526 .","journal-title":"Glia"},{"issue":"12","key":"8518_CR73","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K.,\u2026 Stockwell, B. R. (2014). Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. Journal of the American Chemical Society, 136(12), 4551\u20134556. https:\/\/doi.org\/10.1021\/ja411006a .","journal-title":"Journal of the American Chemical Society"},{"key":"8518_CR74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2016.07.003","volume":"332","author":"J Sripetchwandee","year":"2016","unstructured":"Sripetchwandee, J., Wongjaikam, S., Krintratun, W., Chattipakorn, N., & Chattipakorn, S. C. (2016). A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-beta accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload. Neuroscience, 332, 191\u2013202. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.07.003 .","journal-title":"Neuroscience"},{"issue":"2","key":"8518_CR75","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","volume":"49","author":"C Stack","year":"2010","unstructured":"Stack, C., Ho, D., Wille, E., Calingasan, N. Y., Williams, C., Liby, K., Sporn, M., Dumont, M., & Beal, M. F. (2010). Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington\u2019s disease. Free Radical Biology and Medicine, 49(2), 147\u2013158. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.03.017 .","journal-title":"Free Radical Biology and Medicine"},{"issue":"5932","key":"8518_CR76","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1126\/science.1172871","volume":"324","author":"S Subramaniam","year":"2009","unstructured":"Subramaniam, S., Sixt, K. M., Barrow, R., & Snyder, S. H. (2009). Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science, 324(5932), 1327\u20131330. https:\/\/doi.org\/10.1126\/science.1172871 .","journal-title":"Science"},{"issue":"14","key":"8518_CR77","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1073\/pnas.110078997","volume":"97","author":"M Turmaine","year":"2000","unstructured":"Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., & Davies, S. W. (2000). Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington\u2019s disease. Proceedings of the National Academy of Sciences, 97(14), 8093\u20138097. https:\/\/doi.org\/10.1073\/pnas.110078997 .","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"8518_CR78","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3174\/ajnr.A4617","volume":"37","author":"JM Bergen van","year":"2016","unstructured":"van Bergen, J. M., Hua, J., Unschuld, P. G., Lim, I. A., Jones, C. K., Margolis, R. L.,\u2026 Li, X. (2016). Quantitative susceptibility mapping suggests altered brain iron in premanifest huntington disease. AJNR American Journal of Neuroradiology, 37(5), 789\u2013796. https:\/\/doi.org\/10.3174\/ajnr.A4617 .","journal-title":"AJNR American Journal of Neuroradiology"},{"issue":"3","key":"8518_CR79","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/molecules21030373","volume":"21","author":"A Varela-Lopez","year":"2016","unstructured":"Varela-Lopez, A., Giampieri, F., Battino, M., & Quiles, J. L. (2016). Coenzyme Q and its role in the dietary therapy against aging. Molecules, 21(3), 373. https:\/\/doi.org\/10.3390\/molecules21030373 .","journal-title":"Molecules"},{"issue":"2","key":"8518_CR80","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/sj.onc.1207161","volume":"23","author":"P Vargiu","year":"2004","unstructured":"Vargiu, P., De Abajo, R., Garcia-Ranea, J. A., Valencia, A., Santisteban, P., Crespo, P., & Bernal, J. (2004). The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene, 23(2), 559\u2013568. https:\/\/doi.org\/10.1038\/sj.onc.1207161 .","journal-title":"Oncogene"},{"key":"8518_CR81","doi-asserted-by":"publisher","first-page":"3279061","DOI":"10.1155\/2017\/3279061","volume":"2017","author":"T Velusamy","year":"2017","unstructured":"Velusamy, T., Panneerselvam, A. S., Purushottam, M., Anusuyadevi, M., Pal, P. K., Jain, S., Essa, M. M., Guillemin, G. J., & Kandasamy, M. (2017). Protective effect of antioxidants on neuronal dysfunction and plasticity in Huntington\u2019s Disease. Oxidative Medicine and Cellular Longevity, 2017, 3279061. https:\/\/doi.org\/10.1155\/2017\/3279061 .","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"5","key":"8518_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel, J. P., & DiFiglia, M. (1998). Huntington disease. Journal of Neuropathology & Experimental Neurology, 57(5), 369\u2013384.","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"issue":"10","key":"8518_CR83","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler, N. S., Lorimer, J., Porter, J., Gomez, F., Moskowitz, C., Shackell, E.,\u2026 Landwehrmeyer, B. (2004). Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proceedings of the National Academy of Sciences, 101(10), 3498\u20133503. https:\/\/doi.org\/10.1073\/pnas.0308679101 .","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"8518_CR84","doi-asserted-by":"publisher","first-page":"RRN1231","DOI":"10.1371\/currents.RRN1231","volume":"3","author":"E Wild","year":"2011","unstructured":"Wild, E., Magnusson, A., Lahiri, N., Krus, U., Orth, M., Tabrizi, S. J., & Bjorkqvist, M. (2011). Abnormal peripheral chemokine profile in Huntington\u2019s disease. PLoS Currents, 3, RRN1231. https:\/\/doi.org\/10.1371\/currents.RRN1231 .","journal-title":"PLoS Currents"},{"issue":"7","key":"8518_CR85","doi-asserted-by":"publisher","first-page":"e0159414","DOI":"10.1371\/journal.pone.0159414","volume":"11","author":"S Wongjaikam","year":"2016","unstructured":"Wongjaikam, S., Kumfu, S., Khamseekaew, J., Sripetchwandee, J., Srichairatanakool, S., Fucharoen, S., Chattipakorn, S. C., & Chattipakorn, N. (2016). Combined iron chelator and antioxidant exerted greater efficacy on cardioprotection than monotherapy in iron-overloaded rats. PLoS ONE, 11(7), e0159414. https:\/\/doi.org\/10.1371\/journal.pone.0159414 .","journal-title":"PLoS ONE"},{"issue":"1","key":"8518_CR86","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41598-017-18935-1","volume":"8","author":"C Wu","year":"2018","unstructured":"Wu, C., Zhao, W., Yu, J., Li, S., Lin, L., & Chen, X. (2018). Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells. Scientific Reports, 8(1), 574. https:\/\/doi.org\/10.1038\/s41598-017-18935-1 .","journal-title":"Scientific Reports"},{"issue":"3","key":"8518_CR87","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016). Ferroptosis: Process and function. Cell Death and Differentiation, 23(3), 369\u2013379. https:\/\/doi.org\/10.1038\/cdd.2015.158 .","journal-title":"Cell Death and Differentiation"},{"issue":"7146","key":"8518_CR88","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J.,\u2026 Stockwell, B. R. (2007). RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature, 447(7146), 864\u2013868. https:\/\/doi.org\/10.1038\/nature05859 .","journal-title":"Nature"},{"issue":"3","key":"8518_CR89","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018). The KEAP1-NRF2 system: A thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiological Reviews, 98(3), 1169\u20131203. https:\/\/doi.org\/10.1152\/physrev.00023.2017 .","journal-title":"Physiological Reviews"},{"issue":"1\u20132","key":"8518_CR90","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S.,\u2026 Stockwell, B. R. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell, 156(1\u20132), 317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010 .","journal-title":"Cell"},{"issue":"3","key":"8518_CR91","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang, W. S., & Stockwell, B. R. (2008). Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chemistry & Biology, 15(3), 234\u2013245. https:\/\/doi.org\/10.1016\/j.chembiol.2008.02.010 .","journal-title":"Chemistry & Biology"},{"issue":"3","key":"8518_CR92","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang, W. S., & Stockwell, B. R. (2016). Ferroptosis: Death by lipid peroxidation. Trends in Cell Biology, 26(3), 165\u2013176. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014 .","journal-title":"Trends in Cell Biology"},{"issue":"6","key":"8518_CR93","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nn.3721","volume":"17","author":"H Yano","year":"2014","unstructured":"Yano, H., Baranov, S. V., Baranova, O. V., Kim, J., Pan, Y., Yablonska, S.,\u2026 Friedlander, R. M. (2014). Inhibition of mitochondrial protein import by mutant huntingtin. Nature Neuroscience, 17(6), 822\u2013831. https:\/\/doi.org\/10.1038\/nn.3721 .","journal-title":"Nature Neuroscience"},{"issue":"24","key":"8518_CR94","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1038\/sj.emboj.7601445","volume":"25","author":"Y Zhang","year":"2006","unstructured":"Zhang, Y., Leavitt, B. R., van Raamsdonk, J. M., Dragatsis, I., Goldowitz, D., MacDonald, M. E., Hayden, M. R., & Friedlander, R. M. (2006). Huntingtin inhibits caspase-3 activation. The EMBO Journal, 25(24), 5896\u20135906. https:\/\/doi.org\/10.1038\/sj.emboj.7601445 .","journal-title":"The EMBO Journal"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-018-8518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-018-8518-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-018-8518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T09:07:06Z","timestamp":1662714426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-018-8518-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,2]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["8518"],"URL":"https:\/\/doi.org\/10.1007\/s12017-018-8518-6","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,2]]},"assertion":[{"value":"31 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}